Paper Title
To study the cause, outcome and complications amongst newborns requiring exchange transfusion
Article Identifiers
Authors
DR.SHRUTI RAJAMANI , DR.RUPALI JAIN , DR.VIKAS GUPTA
Keywords
Exchange transfusion, hyperbilirubinemia
Abstract
INTRODUCTION- Treatment modalities for significant hyperbilirubinemia are phototherapy and exchange transfusion. Exchange transfusion in newborns is recommended as emergency management of hyperbilirubinemia and as an effective method to achieve safe bilirubin level in infants at high risk of kernicterus. AIMS AND OBJECTIVES- To study the cause, outcome and complications amongst newborns requiring exchange transfusion. MATERIALS AND METHODS- Retrospective observational study. Data was obtained from neonatal intensive care unit of a tertiary care hospital, in Navi Mumbai, from April 2022 to January 2024. A total of 10 such cases were studied. RESULTS- Amongst the babies who required exchange transfusion, 90% of the cases were outborn cases. While 90% babies were of term gestation, late preterm gestation was noted in only 1 case. Exchange transfusion was performed two times for 20% cases. Analysis of the cause revealed that 50% cases had Rh incompatibility, with a Positive Coomb’s test noted in 20% cases. ABO incompatibility was noted in 30% cases, Hirschsprung’s disease was diagnosed in 1 case, whereas 1 case had significant weight loss. Umbilical Vein Catheterization was done in 90% cases. The procedure was tolerated well by all cases. Commonly observed complications were hypokalemia, hypocalcemia, hyperglycemia, thrombocytopenia and sepsis. Bilirubin encephalopathy was noted in 20% cases, who had presented with a high Bilirubin Induced Neurological Dysfunction (BIND) score. No mortalities were recorded. CONCLUSION- Most common causes for hyperbilirubinemia needing exchange transfusion are Rh incompatibility and ABO incompatibility. In conclusion, exchange transfusion is effective in reducing serum bilirubin value and in preventing kernicterus.
Downloads
How To Cite (APA)
DR.SHRUTI RAJAMANI, DR.RUPALI JAIN, & DR.VIKAS GUPTA (September-2024). To study the cause, outcome and complications amongst newborns requiring exchange transfusion. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(9), a506-a509. https://ijnrd.org/papers/IJNRD2409055.pdf
Issue
Volume 9 Issue 9, September-2024
Pages : a506-a509
Other Publication Details
Paper Reg. ID: IJNRD_300025
Published Paper Id: IJNRD2409055
Downloads: 000121985
Research Area: Humanities All
Country: MUMBAI, MAHARASHTRA, India
Published Paper PDF: https://ijnrd.org/papers/IJNRD2409055.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2409055
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: October 2025
Current Issue: Volume 10 | Issue 10 | October 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 31-Oct-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
